Table 7.
Seroprevalence of AdHu5 and AdC68 neutralizing antibody in different age groups.
| Age groups (years) | N | AdHu5 (%) | AdC68 (%) | P-value |
|---|---|---|---|---|
| Total samples | ||||
| 18–39 | 36 | 20 (55.56) | 9 (25.00) | 0.008 |
| 40–49 | 113 | 69 (61.06) | 32 (28.32) | 0.000 |
| 50–59 | 218 | 152 (69.72) | 84 (38.53) | 0.000 |
| ≥60 | 274 | 200 (72.99) | 115 (41.97) | 0.000 |
| Healthy adult volunteers | ||||
| 18–39 | 11 | 8 (72.73) | 1 (9.09) | 0.002 |
| 40–49 | 27 | 18 (66.67) | 7 (25.93) | 0.003 |
| 50–59 | 74 | 58 (78.38) | 16 (21.62) | 0.000 |
| ≥60 | 92 | 62 (67.39) | 24 (26.09) | 0.000 |
| Cancer patients | ||||
| 18–39 | 25 | 12 (48.00) | 8 (32.00) | 0.248 |
| 40–49 | 86 | 51 (59.30) | 25 (29.07) | 0.000 |
| 50–59 | 144 | 94 (65.28) | 68 (47.22) | 0.002 |
| ≥60 | 182 | 138 (75.82) | 91 (50.00) | 0.000 |